VION Biosciences, a life science platform company focused on specialty materials in the life science research, diagnostic, and drug discovery spaces, announces its second acquisition this August with the acquisition of Ansh Labs, a biotechnology company that focuses on the development, production, and distribution of high-quality immunoassay kits and reagents for research and clinical diagnostics. Based out of Houston, TX, Ansh positions VION to better serve the diagnostic market, with its products enabling customers to conduct important research in various clinical diagnostic areas. This is the third investment under VION Biosciences, Iron Path Capital’s roll-up platform in the life science sector.
Read the full article: VION Biosciences Acquires Second Asset in August, Immunoassay Development Company Ansh Labs //
Source: https://www.businesswire.com/news/home/20240829500545/en/VION-Biosciences-Acquires-Second-Asset-in-August-Immunoassay-Development-Company-Ansh-Labs